Evaluation of Baylis–Hillman Routes to 3- (Aminomethyl)coumarin Derivatives
dc.contributor.author | Olasupo, I | |
dc.contributor.author | Rose, N.R. | |
dc.contributor.author | Klein, R. | |
dc.contributor.author | Adams, L.A. | |
dc.contributor.author | Familoni, O.B. | |
dc.contributor.author | Kaye, P. T. | |
dc.date.accessioned | 2019-08-22T14:24:43Z | |
dc.date.available | 2019-08-22T14:24:43Z | |
dc.date.issued | 2014 | |
dc.description.abstract | The relative merits of two different Baylis–Hillman approaches toward the preparation of coumarin derivatives, containing peptide-like side chains, have been explored. In one approach, use of methyl acrylate as the activated alkene requires a protecting group strategy, an approach that is not necessary when using tert-butyl acrylate. | en_US |
dc.description.sponsorship | National Research Foundation (NRF Grant No. 62273), the Medical Research Council of South Africa (MRC), and Rhodes University | en_US |
dc.identifier.citation | DOI: 10.1080/00397911.2013.803575 | en_US |
dc.identifier.issn | 0039-7911 print=1532-2432 online | |
dc.identifier.uri | https://ir.unilag.edu.ng/handle/123456789/4618 | |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Group, LLC | en_US |
dc.relation.ispartofseries | ;44:2 | |
dc.subject | 3-(Aminomethyl)coumarins; aza-Michael; Baylis–Hillman | en_US |
dc.title | Evaluation of Baylis–Hillman Routes to 3- (Aminomethyl)coumarin Derivatives | en_US |
dc.type | Article | en_US |